Ablation Technology Market | Industry Analysis Report, 2027
The global Ablation Technology market gathered revenue around USD 4.9 Billion in 2020 and market is set to grow USD 11.7 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 13.9% during the prediction period 2021 to 2027.
Growth Factors:
The Market growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed countries and unfavorable regulatory scenario are key factors limiting the growth of this market. Product recalls and therapeutic challenges related to the efficacy of ablation products are key challenges faced by industry players in the global market.
Based on application, the ablation technology market is classified into major segments cardiovascular disease treatment, cancer treatment, ophthalmological treatment, pain management, gynecological treatment, urological treatment, orthopedic treatment, cosmetic/aesthetic surgery, and other applications. Rising disease prevalence and technological advancement in this field will boost market growth.
Based on product, the global ablation technology market is classified into light/laser ablators, radiofrequency ablators, ultrasound ablators, electrical ablators, cryoablation devices, microwave ablators, and hydrothermal ablators/hydromechanical ablators. Each product class is further segmented based on its applications or source of energy. The large share of radiofrequency ablators segment is attributed to the introduction of novel products by major market players and the increasing adoption of RF ablation technology to treat various conditions, such as cancer, cardiac diseases, and ophthalmic diseases.
Based on the type of energy source, the global ablation technology market is classified into light/laser, radiofrequency (RF), electrical, ultrasound, microwave, cryotherapy, and hydrothermal/hydromechanical ablation technologies. The lower cost of radiofrequency ablation, its ease of use, and the rising geriatric population fuel the growth of the radiofrequency ablation market.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Ablation Technology market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Ablation Technology market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
| Report Scope | Details |
| Market Size | USD 11.7 Billion by 2027 |
| Growth Rate | CAGR of 13.9% From 2021 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2021 to 2027 |
| Historic Data | 2017 to 2020 |
| Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
| Segments Covered | Type, Product, Application, End User and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Companies Mentioned | Medtronic, plc., Johnson & Johnson, Abbott, and Boston Scientific Corporation and CONMED Corporation, AngioDynamics, Inc., AtriCure, Inc., Smith & Nephew plc, Olympus Corporation, Varian Medical Systems, Stryker, Dornier MedTech, Cynosure and InMode. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Ablation Technology market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis :
North America was the largest consumer of ablation technology due to the introduction of ablation technology in earlier stages. Increased awareness regarding various treatments using ablation technologies has helped this market to grow. North America was followed by Europe. Asia Pacific region is expected to be the fastest-growing regional market due to availability of a large pool of patients, increased spending capacity of patients; increasing preference to ablation over surgery, geographical expansion of key market players and increasing government investment in the healthcare sector are expected to drive the market growth in Asia Pacific region over the forecast period. India and China are expected to be the key consumers of ablation technology. North America and Europe are mature markets for Ablation Technology and are expected to grow at a relatively sluggish rate over the forecast period.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Ablation Technology Market include: Medtronic, plc., Johnson & Johnson, Abbott, and Boston Scientific Corporation and CONMED Corporation, AngioDynamics, Inc., AtriCure, Inc., Smith & Nephew plc, Olympus Corporation, Varian Medical Systems, Stryker, Dornier MedTech, Cynosure and InMode.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global ablation technology market, by Application
Global ablation technology market, by Product
Global ablation technology market, by Type
Global ablation technology market, by End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Ablation Technology market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Ablation Technology market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Ablation Technology markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Ablation Technology market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Ablation Technology Market, By Application
7.1. Ablation Technology Market, by Application, 2021-2027
7.1.1. Cardiovascular Disease Treatment
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Cancer Treatment
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Ophthalmologic Treatment
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Pain Management
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Gynecological Treatment
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Urological Treatment
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Orthopedic Treatment
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Cosmetic/ Aesthetic Surgery
7.1.8.1. Market Revenue and Forecast (2016-2027)
7.1.9. Other Treatments
7.1.9.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Ablation Technology Market, By Product
8.1. Ablation Technology Market, by Product, 2021-2027
8.1.1. Radiofrequency Ablators
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Laser/Light Ablators
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Ultrasound Ablators
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Electrical Ablators
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Cryoablation Devices
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. Microwave Ablators
8.1.6.1. Market Revenue and Forecast (2016-2027)
8.1.7. Hydrothermal/Hydromechanical Ablators
8.1.7.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Ablation Technology Market, By Type
9.1. Ablation Technology Market, by Type, 2021-2027
9.1.1. Radiofrequency Ablation
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Laser/Light Ablation
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Ultrasound Ablation
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Electrical Ablation
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Cryoablation
9.1.5.1. Market Revenue and Forecast (2016-2027)
9.1.6. Microwave Ablation
9.1.6.1. Market Revenue and Forecast (2016-2027)
9.1.7. Hydrothermal/Hydromechanical Ablation
9.1.7.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Ablation Technology Market, By End User
10.1. Ablation Technology Market, by End User, 2021-2027
10.1.1. Hospitals, surgical centers, and ablation centers
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Ambulatory Surgical Centers
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Medical Spas & Aesthetic clinics
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Other End Users
10.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 11.Global Ablation Technology Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Application (2016-2027)
11.1.2. Market Revenue and Forecast, by Product (2016-2027)
11.1.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Application (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Application (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Product (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.1.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Application (2016-2027)
11.2.2. Market Revenue and Forecast, by Product (2016-2027)
11.2.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Application (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Application(2016-2027)
11.2.6.2. Market Revenue and Forecast, by Product (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Application (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Product (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Application (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Product (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.2.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Application (2016-2027)
11.3.2. Market Revenue and Forecast, by Product (2016-2027)
11.3.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Application (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Application (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Product (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Application (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Product (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Application (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Product (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.3.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Application (2016-2027)
11.4.2. Market Revenue and Forecast, by Product (2016-2027)
11.4.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Application (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Application (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Product (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.6.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Application (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Product (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.7.4. Market Revenue and Forecast, by End User (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Application (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Product (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Type (2016-2027)
11.4.8.4. Market Revenue and Forecast, by End User (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Application (2016-2027)
11.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Application (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Product (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.5.4. Market Revenue and Forecast, by End User (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Application (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Product (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Type (2016-2027)
11.5.6.4. Market Revenue and Forecast, by End User (2016-2027)
Chapter 12. Company Profiles
12.1. Medtronic, plc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Johnson & Johnson
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Abbott
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Boston Scientific Corporation and CONMED Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. AngioDynamics, Inc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. AtriCure, Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Smith & Nephew plc
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Olympus Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Varian Medical Systems
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Stryker, Dornier MedTech
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers